Neurocrine Biosciences
NBIX
#1482
Rank
NZ$19.31 B
Marketcap
$191.30
Share price
-1.75%
Change (1 day)
1.01%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yields for this company